Skip to main content
  • More from ADA
    • Diabetes Care
    • Clinical Diabetes
    • Diabetes Spectrum
    • ADA Standards of Medical Care in Diabetes
    • ADA Scientific Sessions Abstracts
    • BMJ Open Diabetes Research & Care
  • Subscribe
  • Log in
  • My Cart
  • Follow ada on Twitter
  • RSS
  • Visit ada on Facebook
Diabetes

Advanced Search

Main menu

  • Home
  • Current
    • Current Issue
    • Online Ahead of Print
    • ADA Scientific Sessions Abstracts
  • Browse
    • By Topic
    • Issue Archive
    • Saved Searches
    • ADA Scientific Sessions Abstracts
    • Diabetes COVID-19 Article Collection
    • Diabetes Symposium 2020
  • Info
    • About the Journal
    • About the Editors
    • ADA Journal Policies
    • Instructions for Authors
    • Guidance for Reviewers
  • Reprints/Reuse
  • Advertising
  • Subscriptions
    • Individual Subscriptions
    • Institutional Subscriptions and Site Licenses
    • Access Institutional Usage Reports
    • Purchase Single Issues
  • Alerts
    • E­mail Alerts
    • RSS Feeds
  • Podcasts
    • Diabetes Core Update
    • Special Podcast Series: Therapeutic Inertia
    • Special Podcast Series: Influenza Podcasts
    • Special Podcast Series: SGLT2 Inhibitors
    • Special Podcast Series: COVID-19
  • Submit
    • Submit a Manuscript
    • Submit Cover Art
    • ADA Journal Policies
    • Instructions for Authors
    • ADA Peer Review
  • More from ADA
    • Diabetes Care
    • Clinical Diabetes
    • Diabetes Spectrum
    • ADA Standards of Medical Care in Diabetes
    • ADA Scientific Sessions Abstracts
    • BMJ Open Diabetes Research & Care

User menu

  • Subscribe
  • Log in
  • My Cart

Search

  • Advanced search
Diabetes
  • Home
  • Current
    • Current Issue
    • Online Ahead of Print
    • ADA Scientific Sessions Abstracts
  • Browse
    • By Topic
    • Issue Archive
    • Saved Searches
    • ADA Scientific Sessions Abstracts
    • Diabetes COVID-19 Article Collection
    • Diabetes Symposium 2020
  • Info
    • About the Journal
    • About the Editors
    • ADA Journal Policies
    • Instructions for Authors
    • Guidance for Reviewers
  • Reprints/Reuse
  • Advertising
  • Subscriptions
    • Individual Subscriptions
    • Institutional Subscriptions and Site Licenses
    • Access Institutional Usage Reports
    • Purchase Single Issues
  • Alerts
    • E­mail Alerts
    • RSS Feeds
  • Podcasts
    • Diabetes Core Update
    • Special Podcast Series: Therapeutic Inertia
    • Special Podcast Series: Influenza Podcasts
    • Special Podcast Series: SGLT2 Inhibitors
    • Special Podcast Series: COVID-19
  • Submit
    • Submit a Manuscript
    • Submit Cover Art
    • ADA Journal Policies
    • Instructions for Authors
    • ADA Peer Review
Pathophysiology

Effect of a High-Protein, Low-Carbohydrate Diet on Blood Glucose Control in People With Type 2 Diabetes

  1. Mary C. Gannon123 and
  2. Frank Q. Nuttall13
  1. 1Metabolic Research Laboratory and the Section of Endocrinology, Metabolism and Nutrition, Department of Veterans Affairs Medical Center, Minneapolis, Minnesota
  2. 2Department of Food Science and Nutrition, University of Minnesota, Minneapolis, Minnesota
  3. 3Department of Medicine, University of Minnesota, Minneapolis, Minnesota
  1. Address correspondence and reprint requests to Mary C. Gannon, PhD, Metabolic Research Laboratory (111G), VA Medical Center, One Veterans Drive, Minneapolis, MN 55417. E-mail: ganno004{at}umn.edu
Diabetes 2004 Sep; 53(9): 2375-2382. https://doi.org/10.2337/diabetes.53.9.2375
PreviousNext
  • Article
  • Figures & Tables
  • Info & Metrics
  • PDF
Loading

Article Figures & Tables

Figures

  • Tables
  • FIG. 1.
    • Download figure
    • Open in new tab
    • Download powerpoint
    FIG. 1.

    A: Mean body weight while on the control (○) or LoBAG (•) diet. B: Plasma β-hydroxybutyrate concentration after 5 weeks on the control (○) or LoBAG (•) diet.

  • FIG. 2.
    • Download figure
    • Open in new tab
    • Download powerpoint
    FIG. 2.

    A: Mean plasma glucose concentration before (▵) and after (○) 5 weeks on the control diet. Side graph: Net and total 24-h integrated glucose area response. Area response was not significantly different. B: Mean plasma glucose concentration before (▴) and after (•) 5 weeks on the LoBAG diet. Side graph: Net and total 24-h integrated glucose area response. *Both the net and the total area responses were significantly lower after the LoBAG diet (P ≤ 0.05).

  • FIG. 3.
    • Download figure
    • Open in new tab
    • Download powerpoint
    FIG. 3.

    A: Mean serum insulin concentration before (▵) and after (○) 5 weeks on the control diet. Side graph: Net and total 24-h integrated insulin area response. Area response was not significantly different. B: Mean serum insulin concentration before (▴) and after (•) 5 weeks on the LoBAG diet. Side graph: Net and total 24-h integrated insulin area response. *Both the net and the total area responses were significantly lower after the LoBAG diet (P ≤ 0.05).

  • FIG. 4.
    • Download figure
    • Open in new tab
    • Download powerpoint
    FIG. 4.

    Mean %tGHb response during the 5 weeks of the control (○) or LoBAG diet (•). *The tGHb on the test diet was significantly lower at weeks 3, 4, and 5 vs. the control diet (P ≤ 0.05).

  • FIG. 5.
    • Download figure
    • Open in new tab
    • Download powerpoint
    FIG. 5.

    A: Mean plasma glucagon concentration before (▵) and after (○) 5 weeks on the control diet. Side graph: Net and total 24-h integrated glucagon area response. Area response was not significantly different. B: Mean plasma glucagon concentration before (▴) and after (•) 5 weeks on the LoBAG diet. Side graph: Net and total 24-h integrated glucagon area response. *The net and total area responses were significantly higher after the LoBAG diet (P ≤ 0.05).

  • FIG. 6.
    • Download figure
    • Open in new tab
    • Download powerpoint
    FIG. 6.

    A: Mean serum triacylglycerol concentration before (▵) and after (○) 5 weeks on the control diet. Side graph: Net and total 24-h integrated triacylglycerol area response. Area response was not significantly different. B: Mean serum triacylglycerol concentration before (▴) and after (•) 5 weeks on the LoBAG diet. Side graph: Net and total 24-h integrated triacylglycerol area response. *The total area response was significantly lower after the LoBAG diet (P ≤ 0.05).

Tables

  • Figures
  • TABLE 1

    Patient characteristics

    PatientAge (years)Height [in (cm)]Weight [lb (kg)]BMI (kg/m2)tGHb (%)Duration of diabetes (months)Concomitant diseasesMedications
    16974 (188)221 (100)278.760Hypertension, dyslipidemia, coronary heart diseaseSimvastatin, lisinopril, rabeprazole, ASA
    27269 (165)239 (109)3510.012Chronic obstructive pulmonary diseaseTerazosin
    35168 (173)181 (82)278.612NoneASA, naproxen
    46672 (183)196 (89)279.0180HypertensionNone
    58271 (180)204 (93)2811.248NoneLisinopril, ASA
    65672 (183)267 (121)3510.124Obesity, dyslipidemiaNone
    75166 (168)195 (89)3110.014NoneASA, naproxen
    85967 (170)233 (106)369.419Hypertension, obesityLisinopril
    Mean63.370 (176)217 (99)319.646
    Range51–8266–74 (168–188)181–267 (82–121)27–368.6–11.212–180
    • ASA, acetylsalicylic acid.

  • TABLE 2

    Composition of diets

    ControlLoBAG
    Energy (kcal)2,8252,825
    Protein (g)106 (15%)210 (30%)
    Carbohydrate (g)388 (55%)142 (20%)
        Monosaccharides (g)6431
        Disaccharides5016
    Fat (g)94 (30%)158 (50%)
        Monounsaturated (g)2962
        Polyunsaturated (g)2435
        Saturated (g)3330
    Cholesterol (mg)375441
    Dietary fiber (g)2436
PreviousNext
Back to top

In this Issue

September 2004, 53(9)
  • Table of Contents
  • Index by Author
Sign up to receive current issue alerts
View Selected Citations (0)
Print
Download PDF
Article Alerts
Sign In to Email Alerts with your Email Address
Email Article

Thank you for your interest in spreading the word about Diabetes.

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Enter multiple addresses on separate lines or separate them with commas.
Effect of a High-Protein, Low-Carbohydrate Diet on Blood Glucose Control in People With Type 2 Diabetes
(Your Name) has forwarded a page to you from Diabetes
(Your Name) thought you would like to see this page from the Diabetes web site.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Citation Tools
Effect of a High-Protein, Low-Carbohydrate Diet on Blood Glucose Control in People With Type 2 Diabetes
Mary C. Gannon, Frank Q. Nuttall
Diabetes Sep 2004, 53 (9) 2375-2382; DOI: 10.2337/diabetes.53.9.2375

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Add to Selected Citations
Share

Effect of a High-Protein, Low-Carbohydrate Diet on Blood Glucose Control in People With Type 2 Diabetes
Mary C. Gannon, Frank Q. Nuttall
Diabetes Sep 2004, 53 (9) 2375-2382; DOI: 10.2337/diabetes.53.9.2375
del.icio.us logo Digg logo Reddit logo Twitter logo CiteULike logo Facebook logo Google logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Jump to section

  • Article
    • Abstract
    • RESEARCH DESIGN AND METHODS
    • RESULTS
    • DISCUSSION
    • Acknowledgments
    • Footnotes
    • REFERENCES
  • Figures & Tables
  • Info & Metrics
  • PDF

Related Articles

Cited By...

More in this TOC Section

  • A High-Fat Diet Attenuates AMPK α1 in Adipocytes to Induce Exosome Shedding and Nonalcoholic Fatty Liver Development In Vivo
  • Multinucleated Giant Cells in Adipose Tissue Are Specialized in Adipocyte Degradation
  • CEPT1-Mediated Phospholipogenesis Regulates Endothelial Cell Function and Ischemia-Induced Angiogenesis Through PPARα
Show more Pathophysiology

Similar Articles

Navigate

  • Current Issue
  • Online Ahead of Print
  • Scientific Sessions Abstracts
  • Collections
  • Archives
  • Submit
  • Subscribe
  • Email Alerts
  • RSS Feeds

More Information

  • About the Journal
  • Instructions for Authors
  • Journal Policies
  • Reprints and Permissions
  • Advertising
  • Privacy Policy: ADA Journals
  • Copyright Notice/Public Access Policy
  • Contact Us

Other ADA Resources

  • Diabetes Care
  • Clinical Diabetes
  • Diabetes Spectrum
  • Scientific Sessions Abstracts
  • Standards of Medical Care in Diabetes
  • BMJ Open - Diabetes Research & Care
  • Professional Books
  • Diabetes Forecast

 

  • DiabetesJournals.org
  • Diabetes Core Update
  • ADA's DiabetesPro
  • ADA Member Directory
  • Diabetes.org

© 2021 by the American Diabetes Association. Diabetes Print ISSN: 0012-1797, Online ISSN: 1939-327X.